EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 62023TN0019
Case T-19/23: Action brought on 23 January 2023 — Laboratorios Normon v EUIPO — Sofar (NORMOCARE)
Case T-19/23: Action brought on 23 January 2023 — Laboratorios Normon v EUIPO — Sofar (NORMOCARE)
Case T-19/23: Action brought on 23 January 2023 — Laboratorios Normon v EUIPO — Sofar (NORMOCARE)
OJ C 83, 6.3.2023, p. 28–29
(BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
6.3.2023 |
EN |
Official Journal of the European Union |
C 83/28 |
Action brought on 23 January 2023 — Laboratorios Normon v EUIPO — Sofar (NORMOCARE)
(Case T-19/23)
(2023/C 83/36)
Language in which the application was lodged: English
Parties
Applicant: Laboratorios Normon, SA (Tres Cantos, Spain) (represented by: I. Gonzalez-Mogena Gonzalez, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Sofar SpA (Trezzano Rosa, Italy)
Details of the proceedings before EUIPO
Proprietor of the trade mark at issue: Applicant before the General Court
Trade mark at issue: European Union word mark NORMOCARE — European Union trade mark No 17 767 294
Procedure before EUIPO: Cancellation proceedings
Contested decision: Decision of the First Board of Appeal of EUIPO of 26 October 2022 in Case R 916/2022-1
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
order EUIPO and, if appropriate, Sofar Spa to pay the costs of the present proceedings. |
Pleas in law
|
— |
Infringement of Article 60(1)(a) of Regulation (EU) 2017/1001 of the European Parliament and of the Council; |
|
— |
Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |